Composition containing Bifidobacterium for alleviating, preventing or treating rheumatoid arthritis
US10617725B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 11, 2018 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | May 11, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a composition containing Bifidobacterium for alleviating, preventing or treating rheumatoid arthritis. The Bifidobacterium bifidum ATT newly isolated according to the present invention is useful as a rheumatoid arthritis medicine or a probiotic material for alleviating rheumatoid arthritis owing to potent efficacy in treating rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.